These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29356440)

  • 1. Adherence and medication belief in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A nationwide population-based cohort survey.
    Ivarsson B; Hesselstrand R; Rådegran G; Kjellström B
    Clin Respir J; 2018 Jun; 12(6):2029-2035. PubMed ID: 29356440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Information, social support and coping in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension-A nationwide population-based study.
    Ivarsson B; Rådegran G; Hesselstrand R; Kjellström B
    Patient Educ Couns; 2017 May; 100(5):936-942. PubMed ID: 28041647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the relationship between antihypertensive medication satisfaction and adherence in older patients.
    Al-Ruthia YS; Hong SH; Graff C; Kocak M; Solomon D; Nolly R
    Res Social Adm Pharm; 2017; 13(3):602-613. PubMed ID: 27493129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
    Cannon JE; Pepke-Zaba J
    Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.
    Ivarsson B; Hesselstrand R; Rådegran G; Kjellström B
    Chron Respir Dis; 2019; 16():1479972318787906. PubMed ID: 30011997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review.
    Le Bozec A; Korb-Savoldelli V; Boiteau C; Dechartres A; Al Kahf S; Sitbon O; Montani D; Jaïs X; Guignabert C; Humbert M; Savale L; Chaumais MC
    Eur Respir Rev; 2024 Jul; 33(173):. PubMed ID: 38960611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.
    Reynolds K; Viswanathan HN; O'Malley CD; Muntner P; Harrison TN; Cheetham TC; Hsu JW; Gold DT; Silverman S; Grauer A; Morisky DE
    Ann Pharmacother; 2012 May; 46(5):659-70. PubMed ID: 22510666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension.
    Bartenstein P; Saxer S; Appenzeller P; Lichtblau M; Schwarz EI; Ulrich S
    Respiration; 2018; 96(2):127-137. PubMed ID: 29642071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in a national cohort of patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.
    Roman A; Barbera JA; Castillo MJ; Muñoz R; Escribano P
    Arch Bronconeumol; 2013 May; 49(5):181-8. PubMed ID: 23452896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patients' perspective of living with PAH or CTEPH in Sweden].
    Ivarsson B; Hesselstrand R; Rådegran G; Kjellström B
    Lakartidningen; 2019 May; 116():. PubMed ID: 31192407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication adherence in a sample of elderly suffering from hypertension: evaluating the influence of illness perceptions, treatment beliefs, and illness burden.
    Rajpura J; Nayak R
    J Manag Care Pharm; 2014 Jan; 20(1):58-65. PubMed ID: 24511766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication persistence to antihypertensive drug treatment - a cross-sectional study of attitudes towards hypertension and medication in persistent and non-persistent patients.
    Qvarnström M; Kahan T; Kieler H; Brandt L; Hasselström J; Wettermark B
    Blood Press; 2019 Oct; 28(5):309-316. PubMed ID: 31203660
    [No Abstract]   [Full Text] [Related]  

  • 13. The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation.
    Chazova IE; Martynyuk TV; Valieva ZS; Nakonechnikov SN; Nedogoda SV; Salasyuk AS; Taran IN; Gratsianskaya SE
    Ter Arkh; 2018 Sep; 90(9):101-109. PubMed ID: 30701743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension.
    Charalampopoulos A; Gibbs JS; Davies RJ; Gin-Sing W; Murphy K; Sheares KK; Pepke-Zaba J; Jenkins DP; Howard LS
    J Appl Physiol (1985); 2016 Sep; 121(3):623-8. PubMed ID: 27418685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care.
    Lee JD; Burger CD; Delossantos GB; Grinnan D; Ralph DD; Rayner SG; Ryan JJ; Safdar Z; Ventetuolo CE; Zamanian RT; Leary PJ
    Ann Am Thorac Soc; 2020 Dec; 17(12):1576-1582. PubMed ID: 32726561
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.
    Rådegran G; Kjellström B; Ekmehag B; Larsen F; Rundqvist B; Blomquist SB; Gustafsson C; Hesselstrand R; Karlsson M; Kornhall B; Nisell M; Persson L; Ryftenius H; Selin M; Ullman B; Wall K; Wikström G; Willehadson M; Jansson K;
    Scand Cardiovasc J; 2016 Aug; 50(4):243-50. PubMed ID: 27146648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and management of chronic thromboembolic pulmonary hypertension: experience from two expert centers.
    Bazmpani MA; Arvanitaki A; Toumpourleka M; Pitsiou G; Panagiotidou E; Mouratoglou SA; Sianos G; Hadjimiltiades S; Pitsis A; Mayer E; Stanopoulos I; Karvounis H; Giannakoulas G
    Hellenic J Cardiol; 2018; 59(1):16-23. PubMed ID: 28528258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical adherence in patients with systemic lupus erythematosus in Germany: predictors and reasons for non-adherence - a cross-sectional analysis of the LuLa-cohort.
    Chehab G; Sauer GM; Richter JG; Brinks R; Willers R; Fischer-Betz R; Winkler-Rohlfing B; Schneider M
    Lupus; 2018 Sep; 27(10):1652-1660. PubMed ID: 30020020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study.
    Michetti P; Weinman J; Mrowietz U; Smolen J; Peyrin-Biroulet L; Louis E; Schremmer D; Tundia N; Nurwakagari P; Selenko-Gebauer N
    Adv Ther; 2017 Jan; 34(1):91-108. PubMed ID: 27854054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.